Princess Margaret Cancer Biobank , Canada

Certification Status: Approved
Registration Status: Completed

Objective: Princess Margaret Cancer Biobank (PCMB) is a multi-site, large-scale biorepository for human biospecimens and associated clinical data. PMCB offers retrospective and prospective study-specific banking tailored to research needs, including: study protocol development, biospecimen procurement and processing, long-short-term cryostorage and digitial pathology services such as Tissue Microarray (TMA) construction, quantitative image analysis of TMA sections, Laser Capture Microdissection (LCM), digital slide scanning, pathological/clinical analysis for various tumour sites and DNA/RNA extraction. PMCB provides access to retrospective sample collections such fresh, frozen and formalin fixed paraffin embedded (FFPE) surgically resected tissue, biopsy cores, compartmentalized blood components (serum, plasma, buffy coat, PBMC) and various body fluids (urine stool and saliva), along with pathology annotations that are banked in long-term storage for future research.

Registered Biobank Name Princess Margaret Cancer Biobank
Biobank Leader Heidi Wagner
Country Canada
Email for biobank inquiries
Principal Investigator Dr. Neil E. Fleshner
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: